- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
Amgen rides to Rodeo acquisition
CWRU and UTMC-linked Rodeo Therapeutics is set to be acquired by Amgen for $55m in upfront and up to $666m in milestone payments.
Mar 31, 2021Entrada enters series B stage
Ohio State University spinout Entrada Therapeutics has pocketed $116m in a series B round.
Mar 31, 2021OncoResponse raises $40.6m series C
MD Anderson Cancer Center spinout OncoResponse has added $40.6m to its coffers thanks to series C investors including Arch Venture Partners.
Mar 31, 2021Achilles ascends to Nasdaq
Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.
Mar 31, 2021OnQuality orchestrates $20m series A-plus
Cash Capital has returned for OnQuality Pharmaceuticals’s latest round, having already participated in a $15m series A in 2019.
Mar 31, 2021Altaroad finds way to $11.7m
Satt Paris-Saclay’s portfolio company Altaroad has raised $11.7m in funding.
Mar 31, 2021Fortis fortifies with $40m
Existing backers Lilly Asia Ventures and Osage University Partners helped the UCSF cancer therapy spinout close its series A round.
Mar 31, 2021Lilium lands on $3.3bn reverse merger
The vertical take-off and landing jet developer, an Unternehmertum spinout, is joining forces with the Nasdaq-listed Qell Acquisition Corp.
Mar 30, 2021Lava breaks through to public markets
Lava Therapeutics, which is developing cancer treatments based on research at Amsterdam University Medical Centers, floated in a $101m offering.
Mar 30, 2021Multiphoton Optics eyes exit
Heidelberg Instruments Mikrotechnik has acquired the Fraunhofer spinout for an undisclosed sum.
Mar 30, 2021Zigg builds $225m UChicago-backed fund
Zigg Capital has collected $225m from limited partners including University of Chicago to invest in real estate technology developers.
Mar 30, 2021Akoya acts to file for $115m IPO
The tissue analysis device maker, a spinout from Stanford University, has selected the Nasdaq Global Select Market for its initial public offering.
Mar 30, 2021Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
